Impel NeuroPharma Investors

37 investors on Angel Roster list Impel NeuroPharma in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and China.

Investors are matched on the company name in their portfolio, so companies that share the name Impel NeuroPharma can appear together.

Investors listed
37
With verified email
51%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 37 Impel NeuroPharma investors

The most complete profiles first. Showing 37 of 37.

  • Albert ChaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more

    Verified email available

  • Andy SchwabVerified

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more

    Verified email available

  • Brian DanielsVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Deborah PalestrantVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Jason RuthVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Lou TartagliaVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Verified email available

  • Mahendra ShahVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Nathan DauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Rebecca ChenVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Richard GasterVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • David PezeshkiVerified

    Private Equity Firm · United States

    Health CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Verified email available

  • Elliot EhrichVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Johannes HuthVerified

    Private Equity Firm · United Kingdom

    Health CareTelecommunicationsE-commerceCRM

    Portfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more

    Verified email available

  • Jonathan WeissmanVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Joseph BaeVerified

    Private Equity Firm · Hong Kong

    Health CareTelecommunicationsE-commerceCRM

    Portfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more

    Verified email available

  • Mattia CaprioliVerified

    Private Equity Firm · United Kingdom

    Health CareTelecommunicationsE-commerceCRM

    Portfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more

    Verified email available

  • Ming LuVerified

    Venture Capital, Private Equity Firm, Finance Operator

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more

    Verified email available

  • Paul StoneVerified

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Verified email available

  • Qi ZhuVerified

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Raj AgrawalVerified

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more

    Verified email available

  • Suzanne DonohoeVerified

    Private Equity Firm · United States

    Health CareTelecommunicationsE-commerceCRM

    Portfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more

    Verified email available

  • Aaron Royston, M.D.

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more

    Contact details available

  • Frank Kung

    Venture Capital, Founder, Private Equity Firm · United States

    Series BHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more

    Contact details available

  • Jamil M. Beg

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Jaume Pons

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • John Diekman

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Contact details available

  • Mason Freeman

    Venture Capital, Investor · United States

    SeedHealth CareHospitalsGeneticsLife Science

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Mira Chaurushiya

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsAlternative MedicineAndroid

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Scott Rocklage

    Venture Capital, Founder, Private Equity Firm · United States

    SeedHealth CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more

    Contact details available

  • Yvonne Yamanaka

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareWomen FoundedLife ScienceManufacturing

    Portfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more

    Contact details available

  • Andrew Goldberg

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Brandon Freiman

    Venture Capital, Private Equity Firm, Finance Operator · United States

    Health CareTelecommunicationsE-commerceEnterprise Software

    Portfolio: Metro Pacific Hospital Holdings, Broadcom Limited, Cherwell Software, Hetao101 and 79 more

    Contact details available

  • Joseph Victor

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Nina Feng

    Venture Capital, Private Equity Firm · Taiwan

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Peter Kim

    Venture Capital · United States

    Health CareGeneticsLife ScienceSoftware

    Portfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more

    Contact details available

  • Shan Fu

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Robert Mittendorff, MD, MBA

    Venture Capital, Private Equity Firm, Angel/Individual · United States

    Series BArtificial Intelligence (AI)RoboticsElectronic Health Records (EHR)Health and Hospital Services

    Portfolio: TigerConnect, Silk Road Medical, Impel NeuroPharma

    Contact details available

Frequently asked questions

How many Impel NeuroPharma investors are on Angel Roster?

Angel Roster lists 37 Impel NeuroPharma investors. 19 of them (51%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (32), Private Equity Firms (28) and Founder-Investors (5). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Impel NeuroPharma investors invest in?

Among those that list a stage, the most common are Seed (12) and Series B (8).

Where are Impel NeuroPharma investors based?

Most are based in the United States (30), the United Kingdom (2) and China (2).

Which companies have Impel NeuroPharma investors backed?

The most-backed portfolio companies among them are Homology Medicines (24), Crinetics Pharmaceuticals (24), Artiva Biotherapeutics (21), Cidara Therapeutics (21) and Neurogastrx (21).

How do I contact Impel NeuroPharma investors?

Create a free Angel Roster account to search and filter all 37, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.